Symptoms
Common signs and symptoms of Atypical Teratoid Rhabdoid Tumor include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Atypical Teratoid Rhabdoid Tumor.
AT/RT develops when cells in the brain or spinal cord lose function of a important tumor suppressor gene called SMARCB1 (also known as INI1).
AT/RT develops when cells in the brain or spinal cord lose function of a important tumor suppressor gene called SMARCB1 (also known as INI1). This gene normally acts like a cellular brake, preventing cells from growing out of control. When this gene stops working properly, cells can multiply rapidly and form tumors. Think of it like a car losing its brakes - without this crucial control mechanism, cellular growth accelerates dangerously.
In most cases, the gene mutation occurs spontaneously during early development, meaning it's not inherited from parents.
In most cases, the gene mutation occurs spontaneously during early development, meaning it's not inherited from parents. However, in about 10-15% of cases, children inherit a condition called rhabdoid tumor predisposition syndrome from one parent. This inherited condition significantly increases the risk of developing AT/RT and other related tumors, sometimes affecting multiple family members across generations.
Scientists don't yet understand what triggers the initial genetic changes that lead to AT/RT in most cases.
Scientists don't yet understand what triggers the initial genetic changes that lead to AT/RT in most cases. Unlike some cancers linked to environmental factors or lifestyle choices, AT/RT appears to result from random genetic events during brain development. This means parents did nothing to cause their child's tumor, and there's typically nothing that could have been done to prevent it. Research continues to investigate the molecular mechanisms behind this cancer to develop more targeted treatments.
Risk Factors
- Age under 3 years, especially under 2 years
- Family history of rhabdoid tumors
- Rhabdoid tumor predisposition syndrome
- Male gender (slightly higher risk)
- Previous radiation exposure to the head
- Certain inherited genetic mutations
- Having other family members with early-onset cancers
Diagnosis
How healthcare professionals diagnose Atypical Teratoid Rhabdoid Tumor:
- 1
Diagnosing AT/RT typically begins when parents notice concerning symptoms and bring their child to a pediatrician.
Diagnosing AT/RT typically begins when parents notice concerning symptoms and bring their child to a pediatrician. The doctor will perform a thorough physical examination, paying special attention to neurological function and development. If brain tumor symptoms are suspected, the child will be referred immediately to a pediatric neurologist or pediatric oncologist for further evaluation. Time is often critical, so medical teams work quickly to determine the cause of symptoms.
- 2
The primary diagnostic tool is magnetic resonance imaging (MRI) of the brain and spine, which provides detailed pictures of any tumors present.
The primary diagnostic tool is magnetic resonance imaging (MRI) of the brain and spine, which provides detailed pictures of any tumors present. This imaging helps doctors see the tumor's size, location, and whether it has spread to other areas. Additional tests may include: - CT scans if MRI isn't immediately available - Lumbar puncture to check for cancer cells in spinal fluid - Blood tests to assess overall health - Genetic testing to look for inherited conditions
- 3
Confirming an AT/RT diagnosis requires examining tumor tissue under a microscope, which means surgery is usually necessary.
Confirming an AT/RT diagnosis requires examining tumor tissue under a microscope, which means surgery is usually necessary. During this procedure, neurosurgeons remove as much tumor as safely possible while obtaining samples for laboratory analysis. Pathologists then perform special tests to identify the characteristic loss of SMARCB1 protein, which confirms the AT/RT diagnosis. Genetic counseling may be recommended to determine if the tumor resulted from an inherited condition that could affect other family members.
Complications
- AT/RT can cause serious complications both from the tumor itself and from the intensive treatments required to combat it.
- The tumor's aggressive nature means it can quickly interfere with normal brain function, potentially causing permanent neurological damage, developmental delays, or cognitive impairments.
- Depending on the tumor's location, children may experience ongoing problems with movement, speech, vision, or learning abilities even after successful treatment.
- Treatment-related complications can be equally challenging, particularly given the young age of most patients.
- High-dose chemotherapy can damage the immune system, increasing infection risk and requiring careful monitoring in hospital settings.
- Radiation therapy, when necessary, may cause growth problems, cognitive effects, hormone deficiencies, and increased risk of secondary cancers later in life.
- Many survivors require ongoing medical care to address these long-term effects, including hormone replacement therapy, special education services, and regular cancer screening.
- Despite these challenges, advances in supportive care and treatment techniques continue to improve both survival rates and quality of life for AT/RT survivors.
Prevention
- Unfortunately, there's no known way to prevent most cases of AT/RT since they result from random genetic changes during early development.
- Parents cannot take specific actions to reduce their child's risk of developing this tumor, and nothing they did or didn't do during pregnancy caused the cancer.
- The spontaneous nature of most AT/RT cases means prevention strategies that work for other diseases simply don't apply here.
- For the small percentage of families with rhabdoid tumor predisposition syndrome, genetic counseling becomes essential for family planning decisions.
- Families with this inherited condition may choose to pursue genetic testing during pregnancy or preimplantation genetic diagnosis to identify affected embryos.
- However, these decisions involve complex medical and ethical considerations that require careful discussion with genetic counselors and medical specialists.
- The most important prevention-related action involves recognizing symptoms early and seeking immediate medical attention when concerning signs appear.
- While this doesn't prevent the tumor from developing, early detection can significantly impact treatment outcomes.
- Parents should trust their instincts when they notice persistent changes in their child's behavior, development, or physical condition, and shouldn't hesitate to seek medical evaluation for worrying symptoms.
Treatment for AT/RT requires an aggressive, multi-pronged approach coordinated by a specialized pediatric oncology team.
Treatment for AT/RT requires an aggressive, multi-pronged approach coordinated by a specialized pediatric oncology team. Surgery represents the first line of treatment, with neurosurgeons working to remove as much tumor as possible without damaging healthy brain tissue. Complete removal isn't always feasible due to the tumor's location, but maximizing surgical removal significantly improves outcomes. The surgery also provides tissue samples needed to confirm the diagnosis and plan additional treatments.
Chemotherapy forms the backbone of AT/RT treatment, typically involving intensive regimens with multiple powerful medications given over several months.
Chemotherapy forms the backbone of AT/RT treatment, typically involving intensive regimens with multiple powerful medications given over several months. Common chemotherapy drugs include carboplatin, cyclophosphamide, etoposide, and vincristine, often administered in high doses. Many treatment protocols require hospitalization for extended periods, and some involve stem cell rescue procedures where the child's own stem cells are collected and returned after high-dose chemotherapy to help rebuild the immune system.
Radiation therapy decisions depend heavily on the child's age, as radiation can cause significant developmental problems in very young children.
Radiation therapy decisions depend heavily on the child's age, as radiation can cause significant developmental problems in very young children. For children under 3 years, doctors often try to avoid or delay radiation by using intensive chemotherapy instead. When radiation is necessary, newer techniques like proton therapy may be used to minimize damage to healthy brain tissue. Clinical trials are constantly testing new approaches, including targeted therapies and immunotherapy options.
Supportive care throughout treatment addresses the numerous side effects and complications that can arise.
Supportive care throughout treatment addresses the numerous side effects and complications that can arise. This includes managing infections, nutritional support, physical therapy, and addressing developmental concerns. Treatment typically lasts 12-18 months, with regular monitoring continuing for years afterward. Recent advances in understanding AT/RT biology have led to more personalized treatment approaches, with some centers offering molecular profiling to guide therapy selection.
Living With Atypical Teratoid Rhabdoid Tumor
Families navigating an AT/RT diagnosis face an intense and emotionally demanding journey that typically involves months of hospitalization and treatment. Daily life often revolves around medical appointments, chemotherapy sessions, and managing treatment side effects. Parents frequently need to take extended time off work, arrange care for siblings, and coordinate with multiple medical specialists. Social workers and child life specialists at pediatric cancer centers provide essential support in managing these practical challenges while helping families maintain some sense of normalcy.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 10, 2026v1.0.0
- Published by DiseaseDirectory